Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Moving Target - Dutton corrected
1
Jan 06, 2008 08:54AM

"From what I've read lately. Dutton has issued a new adjusted ' lower' target."

It was a typo, from what I understood - they corrected it to 0,92$ this morning after I sent a mail yesterday...

Again it confirmes my theory of Dutton being an important part of PTSC's communications strategy - IMHO it's their job to hold the expectations down, at least as long as the show REALLY starts.

Dutton is very critical, Cohen is more optimistic, it's like a good guy/bad guy-play.

GLTA 

Share
New Message
Please login to post a reply